The unit focuses on translational neuroscience, with a speciality in multiple sclerosis. We are one of the few groups in the World that has truly translational opportunities to move from cell cultures, through animal models, clinical trials and patient care. This is supported by a multi-disciplinary-team of basic and clinician scientists, nursing staff and neurologists. We have a focus on disease prevention and control and biomarkers of neuroinflammation, neuroprotection, repair and symptom control. We have strong history of developing models of and undertaking clinical trials in multiple sclerosis. We strong links with the Pharmaceutical industry and have been involved in drug development for compound synthesis through to licensing of drugs for the treatment of people with neurological disease.